Quantum BioPharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Quantum BioPharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Quantum BioPharma | 6-K: Report of foreign private issuer (related to financial reporting)
Quantum BioPharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Quantum BioPharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Quantum BioPharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Quantum BioPharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Quantum BioPharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Quantum BioPharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Quantum BioPharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Quantum BioPharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Quantum BioPharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
424B5: Prospectus
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K/A: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
FSD Pharma | 6-K/A: Report of foreign private issuer [Rules 13a-16 and 15d-16] (Amendment)
FSD Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
No Data